Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07882043
NA

Milk Free From A1-Type β-Casein With Human Milk Oligosaccharides on Gut Health, Immunity, Cognitive Development, and Temperament in Toddlers

Sponsor: a2 Milk Company Ltd.

View on ClinicalTrials.gov

Summary

The aim of the study is to compare the effects of HMOs in A1-type β-casein-free formula on gut health, immunity, inflammation, gut microflora, cognitive development, and temperament compared with HMOs in conventional formula in toddlers aged 24-30 months.

Official title: Comparing the Effects of Human Milk Oligosaccharides in A1-Type β-Casein-Free Formula vs Conventional Formula in Children Aged 24-30 Months: A Randomised Trial

Key Details

Gender

All

Age Range

24 Months - 30 Months

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2026-11

Completion Date

2027-12

Last Updated

2026-10-20

Healthy Volunteers

Yes

Interventions

OTHER

a2 toddler milk with HMOs

Participants in this arm will daily consume 8 level scoops of a2 Genesis™ HMO Premium Toddler Milk Drink Stage 3, until study completion. Trial duration is 6 months from baseline to last participant last visit (LPLV).

OTHER

Conventional toddler milk with HMOs

Participants in this arm will daily consume 8 level scoops of conventional S3 milk formula with HMOs, until study completion. Trial duration is 6 months from baseline to last participant last visit (LPLV).

Locations (1)

Shenzhen Maternity & Child Healthcare Hospital

Shenzhen, Guagndong, China